A Review on the Emergence of Intelligent Oncology by Sensor-Guided Drug Delivery
Keywords:
Intelligent oncology, Nanomedicine, pH-responsive systems, Sensor-guided drug delivery, Stimuli-responsive drug delivery, Theranostics, Tumor microenvironmentAbstract
For decades, the fight against cancer has been a brutal war of attrition. Chemotherapy, medicine’s necessary evil, operates like a scorched-earth campaign—highly effective, yet devastatingly indiscriminate, destroying both the invasive enemy cells and the healthy host tissue. Conventional cancer chemotherapy often suffers from limitations such as non-specific biodistribution, systemic toxicity, and inadequate drug concentrations at tumor sites, leading to suboptimal therapeutic outcomes and severe side effects. This study presents the transformative potential of integrating advanced sensor technology with drug delivery systems to address these critical oncology challenges. By enabling real-time monitoring and responsive drug release, sensor-enabled platforms promise to revolutionize cancer treatment through enhanced precision, personalization, and efficacy. This study explores innovative approaches where miniaturized biosensors (e.g., electrochemical, optical, pH, temperature, or biomarker-responsive) are incorporated into smart drug carriers (e.g., nanoparticles, hydrogels, implantable microdevices). These intelligent systems are designed to sense specific tumor microenvironmental cues (e.g., abnormal pH, hypoxia, enzyme overexpression) or patient physiological parameters, subsequently triggering the controlled and localized release of anticancer agents. This feedback-controlled mechanism ensures targeted delivery, minimizes off-target accumulation, and allows for on-demand dosing adjustments, thereby maximizing therapeutic effects while significantly reducing systemic toxicity. The integration of sensor technology ushers in an era of truly personalized cancer therapy, offering hope for improved patient quality of life and more effective disease management.
References
N. R. Mulla and K. K. S. Liyakat, “Nano-Materials in Vaccine Formation and Chemical Formulae’s for Vaccination,” Journal of Nanoscience, NanoEngineering & Applications, vol. 15, no. 3, pp. 27-39, Jul. 2025.
V. H. U. Eze et al., “Systematic review of nanoelectronic drug delivery systems advancing technological innovation, clinical integration, and personalized therapy,” Frontiers in Nanotechnology, vol. 7, 2025.
Z. Zhang et al., “Fully Integrated Wearable Control System for Micro/Nanorobot Navigation,” International Journal of Extreme Manufacturing, vol. 7, no. 3, Feb. 2025.
M. Wang et al., “Printable Molecule-Selective Core–Shell Nanoparticles for Wearable and Implantable Sensing,” Nature Materials, vol. 24, pp. 589–598, Feb. 2025.
X. Jing, H. Hu, Y. Sun, B. Yu, H. Cong, and Y. Shen, “The Intracellular and Extracellular Microenvironment of Tumor Site: The Trigger of Stimuli‐Responsive Drug Delivery Systems,” Small Methods, vol. 6, no. 3, Jan. 2022.
P. Mi, “Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics,” Theranostics, vol. 10, no. 10, pp. 4557–4588, 2020.
T. Sun and C. Jiang, “Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments,” Advanced Drug Delivery Reviews, vol. 196, May 2023.
Y. Su et al., “Development of stimuli responsive polymeric nanomedicines modulating tumor microenvironment for improved cancer therapy,” Medical Review, vol. 3, no. 1, pp. 4-30, 2023.
S. M. Hosseini, J. Mohammadnejad, S. Salamat, Z. Beiram Zadeh, M. Tanhaei, and S. Ramakrishna, “Theranostic Polymeric Nanoparticles as a New Approach in Cancer Therapy and Diagnosis: A Review,” Materials Today Chemistry, vol. 29, Apr. 2023.
P. M. Nerkar, K. K. S. Liyakat, B. U. Dhaware, and K. S. S. Liyakat, “Predictive Data Analytics Framework Based on Heart Healthcare System (HHS) Using Machine Learning,” Journal of Advanced Zoology, vol. 44, no. S2, pp. 3673-3686, 2023.
W. Han, F. Liu, G. Liu, H. Li, Y. Xu, and S. Sun, “Research Progress of Physical Transdermal Enhancement Techniques in Tumor Therapy,” Chemical Communications, vol. 59, no. 23, pp. 3339–3359, 2023.
T. G. Schreiner, M. Menéndez-González, O. D. Schreiner, and R. C. Ciobanu, “Intrathecal Therapies for Neurodegenerative Diseases: A Review of Current Approaches and the Urgent Need for Advanced Delivery Systems,” Biomedicines, vol. 13, no. 9, Sep. 2025.
K. S. L. Kazi, “Healthcare Monitoring System Driven by Machine Learning and Internet of Medical Things (MLIoMT),” Convergence of Internet of Medical Things (IoMT) and Generative AI, pp. 385-416, 2025.
S. Indoria, V. Singh, and M.-F. Hsieh, “Recent Advances in Theranostic Polymeric Nanoparticles for Cancer Treatment: A Review,” International Journal of Pharmaceutics, vol. 582, May. 2020.
R. Jia et al., “Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy,” International Journal of Nanomedicine, vol. 16, pp. 1525–1551, Nov. 2020.
W. Zhou, Y. Jia, Y. Liu, Y. Chen, and P. Zhao, “Tumor microenvironment-based stimuli-responsive nanoparticles for controlled release of drugs in cancer therapy,” Pharmaceutics, vol. 14, no. 11, Oct. 2022.
F. Cui, J. Liu, S. Pang, and B. Li, “Recent advance in tumor microenvironment-based stimuli-responsive nanoscale drug delivery and imaging platform,” Frontiers in Pharmacology, vol. 13, Jul. 2022.
